Dr Rahemtulla is a Consultant Haematologist and Honorary Senior Lecturer in the Department of Haematology at the Hammersmith Campus of Imperial College London.
Dr Rahemtulla qualified from University College Hospital Medical School, London and trained in Haematology at the Hammersmith Hospital following which he undertook a period of training in research at the Ontario Cancer Institute, Canada where he obtained his PhD. He then returned to the UK to take up a post as a welcome Senior Research Fellow in Clinical Science in the Nuffield Department of Medicine at the John Radcliffe Hospital, University of Oxford before taking up his current post.
Dr Rahemtulla is in charge of the myeloma programme at Hammersmith Hospital and has an interest in stem cell transplantation for the treatment of haematological malignancies. He is carrying out a number of clinical trials for the treatment of multiple myeloma. Dr Rahemtulla’s laboratory research interests include the pathogenesis of bone destruction in multiple myeloma. His laboratory has investigated the prognostic significance of bone resorption and remodelling markers in patients with myeloma.